Nu-Med Plus (NUMD) Return on Capital Employed (2013 - 2025)
Nu-Med Plus (NUMD) posted Return on Capital Employed of 17.95% for Q4 2025, down 4.81% sequentially from 18.86% in Q3 2025, and down 1132.0% YoY from 1.74% in Q4 2024.
Nu-Med Plus (NUMD) Return on Capital Employed (2013 - 2025) Analysis & Trends
Nu-Med Plus has reported Return on Capital Employed for 13 years, with the latest figure at 17.95% in Q4 2025.
- Quarterly Return on Capital Employed fell 1132.0% year-over-year to 17.95% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 17.95% (down 1132.0% YoY) and the FY2025 annual result came in at 18.09%, down 1163.0% from the prior year.
- Return on Capital Employed fell to 17.95% in Q4 2025 per NUMD's latest filing, from 18.86% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 2413.52% in Q3 2021 and troughed at 1624.23% in Q2 2021.
- A 5-year average of 115.02% and a median of 63.99% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2022: Return on Capital Employed surged 610587 bps in 2021, then plunged 230581 bps in 2022.
- Over 5 years, Return on Capital Employed stood at 712.47% in 2021, then tumbled by 75 bps to 179.98% in 2022, then plunged by 54 bps to 82.21% in 2023, then sank by 64 bps to 29.27% in 2024, then plunged by 39 bps to 17.95% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 17.95%, 18.86%, and 22.49% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 12.08% |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | 19.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.95% |
| Sep 30, 2025 | 18.86% |
| Jun 30, 2025 | 22.49% |
| Mar 31, 2025 | 26.38% |
| Dec 31, 2024 | 29.27% |
| Sep 30, 2024 | 54.03% |
| Jun 30, 2024 | 57.31% |
| Mar 31, 2024 | 68.61% |
| Dec 31, 2023 | 82.21% |
| Sep 30, 2023 | 59.38% |
| Jun 30, 2023 | 109.78% |
| Mar 31, 2023 | 184.57% |
| Dec 31, 2022 | 179.98% |
| Sep 30, 2022 | 107.71% |
| Jun 30, 2022 | 140.87% |
| Mar 31, 2022 | 298.17% |
| Dec 31, 2021 | 712.47% |
| Sep 30, 2021 | 2,413.52% |
| Jun 30, 2021 | -1,624.23% |
| Mar 31, 2021 | -658.87% |